Literature DB >> 23118667

The development of evidence-based care recommendations to improve the safe use of anticoagulants in children.

Cynthia A Barclay1, Karen J Vonderhaar, Eloise A Clark.   

Abstract

Evidence-based care recommendations and standardized protocols improve outcomes. In addition, anticoagulant management has been recognized by The Joint Commission (TJC) as an opportunity for improving patient safety. A National Patient Safety Goal requiring a standardized process for patients receiving anticoagulants was established by TJC. This requirement provided an opportunity to apply evidence-based care recommendations to the issue of safe anticoagulant use. To meet TJC requirement, the following searchable clinical question was drafted: "In children receiving anticoagulation therapy, what are the appropriate dosing, laboratory monitoring, timing, and dosing adjustments for warfarin, unfractionated heparin, and low-molecular-weight heparin to prevent coagulation-related complications?" The team used the Appraisal of Guidelines Research and Evaluation Collaboration (AGREE) instrument to evaluate the quality and relevance of identified guidelines in answering the clinical question. Best Evidence Statements (BESts) were developed for each of the medications (warfarin, low-molecular-weight heparin, and unfractionated heparin). BESts provide the format for the presentation of recommendations, discussion, and methods for point-of-care providers seeking synthesized evidence to guide care decisions. The primary goal of developing and implementing these statements was to standardize the use of anticoagulants and to prevent unsafe practices. A secondary goal was to ensure accessibility of the BESts throughout our organization, including the electronic medical record, various internal division home pages, and our organization's external website. The anticoagulant BESts developed at our organization show how an interprofessional approach to patient care results in the development of evidence-based care recommendations. The BESts were developed to standardize care associated with the use of anticoagulants and to provide dosing and monitoring parameters to ensure safe care to all patients receiving these medications. The development of evidence-based care recommendations can be accomplished with a focused interprofessional team dedicated to providing the safest possible care to patients.

Entities:  

Keywords:  anticoagulants; children; evidence-based

Year:  2012        PMID: 23118667      PMCID: PMC3470435          DOI: 10.5863/1551-6776-17.2.155

Source DB:  PubMed          Journal:  J Pediatr Pharmacol Ther        ISSN: 1551-6776


  18 in total

1.  Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project.

Authors: 
Journal:  Qual Saf Health Care       Date:  2003-02

2.  Quality of evidence-based pediatric guidelines.

Authors:  Nicole Boluyt; Carsten R Lincke; Martin Offringa
Journal:  Pediatrics       Date:  2005-05       Impact factor: 7.124

3.  Creating quality evidence summaries on a clinician's schedule.

Authors:  Susan McGee; Eloise Clark
Journal:  J Nurs Adm       Date:  2010-01       Impact factor: 1.737

4.  Antithrombotic and thrombolytic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Jack Hirsh; Gordon Guyatt; Gregory W Albers; Robert Harrington; Holger J Schünemann
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

5.  The use of low molecular weight heparin in pediatric patients: a prospective cohort study.

Authors:  D Dix; M Andrew; V Marzinotto; K Charpentier; S Bridge; P Monagle; G deVeber; M Leaker; A K Chan; M P Massicotte
Journal:  J Pediatr       Date:  2000-04       Impact factor: 4.406

6.  Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Paul Monagle; Elizabeth Chalmers; Anthony Chan; Gabrielle deVeber; Fenella Kirkham; Patricia Massicotte; Alan D Michelson
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

7.  The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  James D Douketis; Peter B Berger; Andrew S Dunn; Amir K Jaffer; Alex C Spyropoulos; Richard C Becker; Jack Ansell
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

8.  Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Shannon M Bates; Ian A Greer; Ingrid Pabinger; Shoshanna Sofaer; Jack Hirsh
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

9.  Long-term treatment of thrombosis with enoxaparin in pediatric and adolescent patients.

Authors:  Nick Merkel; Gudrun Gunther; Rosemarie Schobess
Journal:  Acta Haematol       Date:  2006       Impact factor: 2.195

10.  Heparin overdose scare in 14 babies at Texas hospital.

Authors: 
Journal:  Healthcare Benchmarks Qual Improv       Date:  2008-09
View more
  1 in total

1.  Normal saline (0.9% sodium chloride) versus heparin intermittent flushing for the prevention of occlusion in long-term central venous catheters in infants and children.

Authors:  Natalie K Bradford; Rachel M Edwards; Raymond J Chan
Journal:  Cochrane Database Syst Rev       Date:  2020-04-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.